Compare the exact preparation and labeled serving

The checked tablet declares 277 mg boswellia extract containing 180 mg boswellic acids, alongside separately listed celery, ginger and turmeric extracts. Do not add constituent weights to their parent extract or ignore the other herbs.

The amounts below reproduce the inspected manufacturer online panel. They describe labeled servings, not an individualized regimen. Confirm your selected package and review the full ingredient list and dietary attributes on the product page.

Declared manufacturer amounts checked October 14, 2026; compare the exact selected package
ProductDeclared serving factsImportant distinction
Boswellia ComplexView product โ†’Declared serving factsEach Serving Size (1 Tablet) contains: Calories 5, Calcium 37 mg, Boswellia gum oleoresin 7:1 extract 277 mg (from Boswellia serrata gum oleoresin 1.9 g, Containing boswellic acids 180 mg), Celery Seed fruit 6:1 extract 166.7 mg (from Apium graveolens fruit 1.0 g), Ginger rhizome 10:1 extract 30 mg (from Zingiber officinale rhizome 300 mg), Turmeric rhizome 25:1 extract 84.4 mg (from Curcuma longa rhizome 2.1 g, Containing curcuminoids 70.4 mg).Important distinctionRead the complete Boswellia Complex ingredient list and current package. The serving facts describe this formula; a shared ingredient does not make it equivalent to another product.
NeuroRegenexView product โ†’Declared serving factsEach Serving Size (2 Tablets) contains: Calories 5, Calcium 142 mg, Gotu Kola leaf 10:1 extract 200 mg (from Centella asiatica leaf 2 g, Containing triterpenes 40 mg), Turmeric rhizome 55:1 extract 156 mg (from Curcuma longa rhizome 8.6 g, Containing curcuminoids 135 mg, Equivalent to curcumin 110 mg), Boswellia oleo-gum-resin 23:1 extract 88 mg (from Boswellia serrata oleo-gum-resin 2 g), Bupleurum root 6:1 extract 166.7 mg (from Bupleurum falcatum root 1 g).Important distinctionRead the complete NeuroRegenex ingredient list and current package. The serving facts describe this formula; a shared ingredient does not make it equivalent to another product.

References: WSNC Boswellia Complex recorded label details โ†— ยท WSNC NeuroRegenex recorded label details โ†— ยท Boswellia: Usefulness and Safety | NCCIH โ†—

What the ingredient evidence can establish

Some small studies suggest benefits for osteoarthritis symptoms, but NCCIH calls for larger, higher-quality research. Limited findings in other conditions do not establish boswellia as a general anti-inflammatory treatment.

Standardized extracts differ in constituent profiles, and trials do not necessarily use the same finished formula. A boswellic-acid number is a composition fact, not proof that a combination produces a particular clinical outcome.

References: Boswellia: Usefulness and Safety | NCCIH โ†—

Review suitability, medicines and the whole formula

Review medicines and the full combination with your practitioner, especially during pregnancy or nursing or with allergy concerns. Do not replace prescribed asthma, joint or other treatment based on ingredient mechanisms.

Ask whether the intended comparison is boswellia itself or the complete joint-support blend. Keep established movement and clinical care alongside any supplement discussion.

References: WSNC Boswellia Complex recorded label details โ†— ยท WSNC NeuroRegenex recorded label details โ†— ยท Boswellia: Usefulness and Safety | NCCIH โ†—

Prepare a focused practitioner conversation

Bring the selected label, your reason for considering boswellia, and a list of medicines and other supplements. Compare the intended outcome with the specific preparation studied, and agree how suitability and any benefit will be assessed.

Manufacturer suggested-use text checked for these products: Boswellia Complex: 1 tablet 2 - 4 times daily, or as directed. NeuroRegenex: 2 tablets, 3 times daily, or as directed Cautions: Contraindicated in known allergy to Gotu Kola. Not to be used in pregnancy and lactation unless otherwise directed by a qualified healthcare professional.

These are separate product instructions, not one combined supplement schedule. Keep the current package directions with your practitioner plan; ingredient research does not override manufacturer labeling.

References: WSNC Boswellia Complex recorded label details โ†— ยท WSNC NeuroRegenex recorded label details โ†— ยท Boswellia: Usefulness and Safety | NCCIH โ†—

Protocol label reading

These kits contain a product compared in this guide. That ingredient match does not establish effects for the complete kit or individual suitability. Review all components with your practitioner.

Common questions

How should I compare boswellia supplement labels?

The checked tablet declares 277 mg boswellia extract containing 180 mg boswellic acids, alongside separately listed celery, ginger and turmeric extracts. Do not add constituent weights to their parent extract or ignore the other herbs.

Does ingredient research prove the complete formula works?

Standardized extracts differ in constituent profiles, and trials do not necessarily use the same finished formula. A boswellic-acid number is a composition fact, not proof that a combination produces a particular clinical outcome.

What should I discuss before considering boswellia?

Review medicines and the full combination with your practitioner, especially during pregnancy or nursing or with allergy concerns. Do not replace prescribed asthma, joint or other treatment based on ingredient mechanisms.

Evidence and product label sources

WSNC label links below present recorded Standard Process product information on our site. Noncommercial references explain ingredients, evidence limits and safety; they do not verify every formula amount or establish a treatment outcome for a finished product or protocol. The referenced organizations do not endorse this store.

Manufacturer nutrition-panel amounts shown here were checked October 14, 2026. Confirm the current packaging, directions and dietary information before use. Your healthcare practitioner can help assess individual suitability.

How we research products โ†’ ยท Prepare a practitioner conversation โ†’